Skip to main content
. 2022 Apr 13;15(4):581–589. doi: 10.1159/000524381

Table 2.

Prevalence of lifestyle factors and comorbidities in obese young men and women

Men (n = 1,325) N (%) Women (n = 725) N (%) p value
Alcohol consumption
 Nondrinker 115 (8.9) 145 (19.7)
 Moderate drinker 841 (65.5) 426 (60.0) <0.001
 Heavy drinker 358 (25.6) 149 (20.4)
Smoking status
 Nonsmoker 737 (56.8) 650 (89.8) <0.001
 Current smoker 577 (43.2) 70 (10.2)
Physical activity
 Low 628 (48.5) 392 (54.7)
 Middle 420 (33.3) 239 (35.9) <0.001
 High 205 (18.3) 61 (9.4)
Excessive energy intake
 No 813 (76.4) 531 (80.6) 0.071
 Yes 269 (23.6) 122 (19.4)
Fat intake, %
 <30 867 (79.5) 524 (80.2) 0.772
 ≥30 215 (20.5) 129 (19.8)
Frequency of eating out
<1 meal/day 512 (47.4) 535 (79.7) <0.001
≥1 meal/day 571 (52.6) 118 (20.3)
Comorbidities
 Abdominal obesitya 888 (65.9) 465 (62.2) 0.141
 Diabetes 79 (6.4) 52 (7.1) 0.569
 Hypertension 340 (24.5) 98 (12.8) <0.001
 Hypercholesterolemia 224 (17.2) 95 (13.0) 0.019
 Hypertriglyceridemia 312 (32.5) 75 (13.2) <0.001
 Elevated ALT 451 (34.6) 74 (9.6) <0.001
Self-perceived weight status
 Obese 1,167 (88.7) 705 (98.0) <0.001
 Nonobese 147 (11.3) 15 (2.0)
Weight control effort in the past 1 year
 Yes 914 (69.2) 589 (83.4) <0.001
 No 392 (30.8) 129 (16.6)
Weight control strategies
 Exercise
  Yes 747 (82.2) 402 (67.1) <0.001
  No 167 (17.8) 187 (32.9)
 Diet therapy
  Yes 642 (71.9) 479 (79.7) 0.005
  No 272 (28.1) 110 (20.3)
 Pharmacotherapy
  Yes 11 (1.0) 85 (14.3) <0.001
  No 903 (99.0) 504 (85.7)

Values are presented as unweighted number (weighted percentage). ALT, alanine aminotransferase.

a

Abdominal obesity was defined as WC ≥90 cm in men and ≥85 cm in women.